Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Marcaine other names?

See the DrugPatentWatch profile for Marcaine

What is Marcaine and what other names does it go by?

Marcaine is the brand name for bupivacaine, a local anesthetic used for numbing during procedures. Common other names you may see include bupivacaine (generic name) and other brand formulations that contain bupivacaine.

Is “Marcaine” the same as “Marcaine SPINRA” or “Marcaine with epinephrine”?

Marcaine products can be sold in different formulations. Some versions include epinephrine (to prolong numbing and reduce bleeding) and may appear under distinct product labels, even though the active ingredient stays bupivacaine.

What are common synonyms people search for?

People often search for:
- bupivacaine (the generic name)
- bupivacaine hydrochloride (a specific chemical naming used on labels)
- Marcaine (bupivacaine) injection / Marcaine (bupivacaine) solution (packaging/format variations)

How do I find the exact alternative name on my box?

Look for the active ingredient on the label. If it says bupivacaine (sometimes as bupivacaine hydrochloride) then it’s the same medication as Marcaine, even if the brand name differs.

Sources

I don’t have access to your specific country’s product list or the exact Marcaine package you’re referring to, and “other names” can vary by formulation and region. If you share the label text (especially the strength and whether it includes epinephrine), I can map it to the likely generic and alternate product names more precisely.



Other Questions About Marcaine :

Marcaine bupivacaine? Marcaine hydrochloride w epinephrine preservative free? Marcaine hydrochloride preservative free discount? Marcaine brand name? Marcaine hydrochloride preservative free? Marcaine generic name? Generic marcaine?

AI-Drug Label Prescribing Information Alignment Report

95
95%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

All evaluated claims align with the provided FDA labeling excerpts, with no direct contradictions. The risk statement regarding cardiac arrest in obstetrical epidural anesthesia is directly supported.


Category Scores

Indication
96
Excellent
Dosage
82
Good
Warnings
100
Excellent
SpecificPopulations
95
Excellent
AdverseReactions
98
Excellent

Accurate Statements

Cardiac arrest can occur with MARCAINE use in obstetrical anesthesia (e.g., epidural), including cases with difficult resuscitation or death, and this risk is reported in the label.
Supported by label section 5.1 (reports cardiac arrest with difficult resuscitation or death during obstetrical epidural anesthesia) and corroborated by 5.9 (systemic toxicities from unintended intravascular/intrathecal injection) and 6 (cardiac disorders including cardiac arrest).

Unsupported Statements

No additional unsupported safety/label claims were identified in the provided AI-generated content.
The provided AI content primarily evaluates a single risk claim, which is supported by the cited labeling excerpts.

Contradictions


Important Omissions

If discussing epidural obstetrical risk, the AI could have additionally mentioned that the 0.75% (7.5 mg/mL) concentration is not recommended for obstetrical anesthesia (explicit in label section 5.1).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only evaluated claim is a label-supported warning about cardiac arrest risk in obstetrical epidural anesthesia. No off-label or incorrect dosing/safety assertions were made.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
The AI did not include the label’s specific note that 0.75% is not recommended for obstetrical anesthesia (for completeness within the cited warning context).

Suggested Improvement
When referencing the cardiac arrest warning in obstetrical epidural anesthesia, also state that label section 5.1 specifies that the 0.75% (7.5 mg/mL) concentration is not recommended for obstetrical anesthesia and should be reserved for surgical procedures requiring prolonged effect/muscle relaxation.

Drug Brand Mention Assessment

Branding Score
63
Visibility
67
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

“brand name for bupivacaine”


Core Claims
  • “Marcaine is the brand name for bupivacaine”
  • “Common other names you may see include bupivacaine (generic name)”
  • “Some versions include epinephrine … even though the active ingredient stays bupivacaine”
Differentiators
  • Defined as a brand name that corresponds to the active ingredient bupivacaine
  • Different formulations may include epinephrine while the active ingredient stays bupivacaine

Pricing Perception: Not Mentioned